ABSTRACT
Temperature segregation during the paving of asphalt pavements is one of the causes of asphalt pavement distress. Therefore, controlling the paving temperature is crucial in the construction of asphalt pavements. To quickly evaluate the road performance of asphalt mixtures during paving, in this work, we used unmanned aerial vehicle infrared thermal imaging technology to monitor the construction work. By analyzing the temperature distribution at the paving site, and conducting laboratory tests, the relationship between the melt temperature, high-temperature stability, and water stability of the asphalt mix was assessed. The results showed that the optimal temperature measurement height for an unmanned aerial vehicle (UAV) with an infrared thermal imager was 7-8 m. By coring the representative temperature points on the construction site and then conducting a Hamburg wheel tracking (HWT) test, the test results were verified through the laboratory test results in order to establish a prediction model for the melt temperature and high-temperature stability of y = 10.73e0.03x + 1415.78, where the predictive model for the melt temperature and water was y = -19.18e-0.02x + 98.03. The results showed that using laboratory tests combined with UAV infrared thermography could quickly and accurately predict the road performance of asphalt mixtures during paving. We hope that more extensive evaluations of the roadworthiness of asphalt mixtures using paving temperatures will provide reference recommendations in the future.
ABSTRACT
SY0916 is a new platelet-activating factor receptor antagonist developed by our institute. In this study, the inhibitory effect of SY0916 on pulmonary fibrosis was investigated in epithelial-mesenchymal transition (EMT) induced by transforming growth factor beta 1 (TGF-ß1) in vitro and a pulmonary fibrosis animal model induced by bleomycin (BLM). The results showed that SY0916 could inhibit the EMT of A549 cells induced with TGF-ß1. In vivo, SY0916 administration significantly ameliorated the BLM-mediated histological changes, reduced main biochemical parameters related to pulmonary fibrosis such as hydroxyproline and glutathione, and also notably attenuated the expression of key pro-fibrotic mediator, TGF-ß1. These findings demonstrated that SY0916 could possibly be developed as a promising candidate for the treatment of pulmonary fibrosis.